Kameda Medical Center

Chiba 296-8602

1 studies enrolling now · 2 studies all time

What they study most

Hematological Malignancies, Multiple Myeloma

Studies at this site

• A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now